4 transcripts
LGND
Earnings call transcript
NASDAQ
2024 Q2
6 Aug 24
Hadden; and Senior Vice President of Investment and Head of Clinical Strategy, Dr. Karen Reeves.
This call is being recorded and the audio portion
LGND
Earnings call transcript
NASDAQ
2024 Q1
7 May 24
, Investments and Business Development, Paul Hadden and our Senior VP of Clinical Strategy Investment, Dr. Karen Reger.
This call is being recorded
LGND
Earnings call transcript
NASDAQ
2023 Q4
27 Feb 24
that was inconsistent with our core financial strategy. This enabled a headcount reduction from over 170 to 35 employees. This operational streamlining
LGND
Earnings call transcript
NASDAQ
2023 Q2
8 Aug 23
business strategy to accumulate additional assets and drive further cash flow and profitability into our business. We have a strong balance sheet, no debt
- Prev
- 1
- Next